7Baggers
 Chardan Capital Maintains 'Buy' Rating on COYA with $14 Target |  GuruFocus Fri, 14 Nov 2025 14:20:24 GMT
 btig maintains coya therapeutics (coya) buy recommendation  Nasdaq Fri, 14 Nov 2025 00:06:00 GMT
 BTIG Raises Price Target for COYA, Maintains Buy Rating | COYA S  GuruFocus Thu, 13 Nov 2025 19:08:57 GMT
 Coya Therapeutics Shrinks Its Losses As R&D Progresses  Finimize Wed, 12 Nov 2025 14:28:51 GMT
 Coya Therapeutics reports Q3 EPS (13c), consensus (30c)  TipRanks Wed, 12 Nov 2025 13:59:10 GMT
 Coya Therapeutics Reports Q3 2025 Financial Results  TipRanks Wed, 12 Nov 2025 13:38:07 GMT
 coya therapeutics, inc. sec 10-q report  TradingView Wed, 12 Nov 2025 13:23:00 GMT
 Coya Therapeutics' Q3 net loss narrows  MarketScreener Wed, 12 Nov 2025 13:14:08 GMT
 Precision Trading with Coya Therapeutics Inc. (COYA) Risk Zones  news.stocktradersdaily.com Sun, 09 Nov 2025 21:44:04 GMT
 addf invests $5m in coya to support phase 2 dementia trial  Longevity.Technology Fri, 07 Nov 2025 17:09:38 GMT
 IL-2 and GLP-1 receptor agonist combination tackles neuroinflammation  Drug Target Review Wed, 05 Nov 2025 09:02:57 GMT
 meet 6 of the fastest-growing scaleup companies in houston right now  InnovationMap Tue, 04 Nov 2025 15:51:27 GMT
 published on: 2025-10-30 03:50:07  newser.com Thu, 30 Oct 2025 08:50:07 GMT
 coya therapeutics closes $23 million public offering of common stock by investing.com  Investing.com Australia Tue, 28 Oct 2025 11:58:39 GMT
 published on: 2025-10-28 03:36:35  newser.com Tue, 28 Oct 2025 08:36:35 GMT
 Here’s Greenlight Capital’s Update on Coya Therapeutics (COYA)  Yahoo Finance Tue, 28 Oct 2025 07:00:00 GMT

Coya Therapeutics Inc.
(NASDAQ:COYA) 


Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs).

Founded: 2020
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS

Share this website to your friends